MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-15-2026
Annovis Bio EBITDA per Share 2011-2026 | ANVS
Annual EBITDA per Share Annovis Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.44 | -2.19 | -4.99 | -3.13 | -1.91 | -0.795 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.795 | -4.99 | -2.41 |
Quarterly EBITDA per Share Annovis Bio
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.65 | -0.38 | -0.32 | -0.36 | - | -0.34 | -0.69 | -0.74 | - | -1.65 | -1.09 | -1.22 | - | -0.79 | -0.73 | -0.64 | - | -0.35 | -0.34 | -0.47 | - | -0.23 | -0.37 | -0.13 | - | -0.86 | -1.08 | -0.66 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.13 | -1.65 | -0.64 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-0.71 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-0.82 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | France |
 |
AstraZeneca PLC
AZN
|
12.6 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-23.7 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-3.51 | - | 0.74 % | $ 768 M |  Israel |
 |
Galera Therapeutics
GRTX
|
-0.03 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.03 | - | -18.52 % | $ 27.3 M | Britain |
 |
Esperion Therapeutics
ESPR
|
0.29 | $ 3.14 | 0.16 % | $ 653 M | USA |
 |
Eton Pharmaceuticals
ETON
|
0.12 | $ 35.13 | 1.97 % | $ 945 M | USA |
|
Forte Biosciences
FBRX
|
-5.45 | $ 21.7 | 6.84 % | $ 281 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-2.84 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
-1.81 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
-1.29 | - | -7.31 % | $ 87 M | USA |
 |
Grifols, S.A.
GRFS
|
1.75 | $ 8.14 | -0.67 % | $ 5.53 B |  Spain |
 |
Generation Bio Co.
GBIO
|
-2.06 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-0.28 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | USA |
 |
BioNTech SE
BNTX
|
-5.81 | $ 91.21 | 0.94 % | $ 22 B | Germany |
 |
Autolus Therapeutics plc
AUTL
|
-0.99 | $ 1.66 | 2.47 % | $ 442 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | Israel |
 |
Heron Therapeutics
HRTX
|
-0.06 | $ 0.87 | 2.78 % | $ 145 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-3.85 | - | -4.36 % | $ 27 M | USA |
 |
Compugen Ltd.
CGEN
|
0.34 | $ 2.61 | -3.7 % | $ 244 M | Israel |
 |
Incyte Corporation
INCY
|
8.24 | $ 97.69 | 0.63 % | $ 19.1 B | USA |
 |
Anika Therapeutics
ANIK
|
-0.4 | $ 15.09 | -0.33 % | $ 216 M | USA |
 |
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
-3.37 | - | 5.93 % | $ 314 M | Canada |
 |
Ionis Pharmaceuticals
IONS
|
-1.28 | $ 75.94 | 1.17 % | $ 12.2 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 3.4 | 2.41 % | $ 5.6 M | Israel |
 |
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | USA |
 |
Coherus BioSciences
CHRS
|
-1.54 | $ 1.6 | 5.61 % | $ 187 M | USA |
 |
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
-1.29 | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 20.88 | 2.0 % | $ 2.66 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | USA |